UBX: Unity Biotechnology, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 25.26
Enterprise Value ($M) 5.46
Book Value ($M) 28.40
Book Value / Share 1.69
Price / Book 0.89
NCAV ($M) 9.31
NCAV / Share 0.55
Price / NCAV 2.71

Profitability (mra)
Return on Invested Capital (ROIC) -0.72
Return on Assets (ROA) -0.35
Return on Equity (ROE) -0.68

Liquidity (mrq)
Quick Ratio 5.94
Current Ratio 5.94

Balance Sheet (mrq) ($M)
Current Assets 46.60
Assets 65.69
Liabilities 37.29
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -39.06
Net Income -39.86
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Alyeska Investment Group, L.P. 9.99 18.17
05-10 13G/A Fmr Llc 4.02 -55.98

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-15 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-18 2,818 4,163 67.69
2024-04-17 3,946 28,482 13.85
2024-04-16 5,231 61,777 8.47
2024-04-15 9,456 35,729 26.47

(click for more detail)

Similar Companies
TWST – Twist Bioscience Corporation TXMD – TherapeuticsMD, Inc.
TYRA – Tyra Biosciences, Inc. UTHR – United Therapeutics Corporation
VERV – Verve Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io